EUVIMEDEUVIMED entdecken
Crossref

Ceramide accumulation and microbiota-derived sphingolipids: A novel axis in obesity-linked diabetic inflammation

Saksham Saxena, Irshad Ahmed, Rajeev Kumar Jha, Sushree Swagatika, Naveen Kumar, Mansi Saxena, Susmita Chakrabarty, Ranjay Kumar Choudhary, Aniruddha Bhattacharjee

Obesity Medicine · 2026-07 · 62 · 100723

DOI: 10.1016/j.obmed.2026.100723 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Obesity Medicine, 2026-07. Verfasst von Saksham Saxena und 8 weiteren Autor:innen. Die Arbeit nennt 137 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Saxena, S., Ahmed, I., Jha, R. K., Swagatika, S., Kumar, N., Saxena, M., Chakrabarty, S., Choudhary, R. K., & Bhattacharjee, A. (2026). Ceramide accumulation and microbiota-derived sphingolipids: A novel axis in obesity-linked diabetic inflammation. Obesity Medicine, 62, 100723. https://doi.org/10.1016/j.obmed.2026.100723

Vancouver

Saxena S, Ahmed I, Jha RK, Swagatika S, Kumar N, Saxena M, et al. Ceramide accumulation and microbiota-derived sphingolipids: A novel axis in obesity-linked diabetic inflammation. Obesity Medicine. 2026;62:100723. doi:10.1016/j.obmed.2026.100723

BibTeX
@article{Saxena2026,
  author = {Saxena, Saksham and Ahmed, Irshad and Jha, Rajeev Kumar and Swagatika, Sushree and Kumar, Naveen and Saxena, Mansi and Chakrabarty, Susmita and Choudhary, Ranjay Kumar and Bhattacharjee, Aniruddha},
  title = {Ceramide accumulation and microbiota-derived sphingolipids: A novel axis in obesity-linked diabetic inflammation},
  journal = {Obesity Medicine},
  year = {2026},
  volume = {62},
  pages = {100723},
  doi = {10.1016/j.obmed.2026.100723}
}
Kostenlos starten →